EyePoint Pharmaceuticals, Inc. (EYPT) vs Treace Medical Concepts, Inc. (TMCI)
A side-by-side comparison of EyePoint Pharmaceuticals, Inc. and Treace Medical Concepts, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
EYPT
EyePoint Pharmaceuticals, Inc.
$3.17HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
TMCI
Treace Medical Concepts, Inc.
$4.00HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — EYPT vs TMCI
growth of $100 · dividends reinvested · last 5yEYPT -66.5% (-19.6%/yr)TMCI -82.5% (-29.4%/yr)EYPT compounded faster over this window
EYPT TMCI
EYPT vs TMCI: by the numbers
- •EYPT is the larger company ($266M vs $259M market cap).
- •Both run net losses; TMCI's is the smaller (-28.99% vs -10994.73% net margin).
- •TMCI grew revenue faster over the past five years (21.44% vs -41.05% CAGR).
Metrics side by side
Valuation
| Metric | EYPT | TMCI |
|---|---|---|
| P/S ratio | 95.29 | 1.26 |
| P/B ratio | 1.60 | 3.83 |
Profitability
| Metric | EYPT | TMCI |
|---|---|---|
| Gross margin | 93.41% | 79.45% |
| Operating margin | -775.98% | -26.17% |
| Net margin | -10994.73% | -28.99% |
| ROE | -184.27% | -87.86% |
| ROIC | -170.19% | -37.64% |
Growth (annualized)
| Metric | EYPT | TMCI |
|---|---|---|
| Revenue CAGR (5Y) | -41.05% | 21.44% |
| Total return CAGR (5Y) | -21.68% | -29.41% |
Frequently asked
- Which has grown faster, EYPT or TMCI?
- Over the past five years, TMCI grew revenue faster — EYPT at a -41.05% CAGR versus TMCI at 21.44%.
- How have EYPT and TMCI total returns compared?
- Over the past 5 years, EYPT delivered -21.68% and TMCI delivered -29.41% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
EyePoint Pharmaceuticals ROETreace Medical Concepts ROEEyePoint Pharmaceuticals operating marginTreace Medical Concepts operating marginEyePoint Pharmaceuticals revenue growthTreace Medical Concepts revenue growthEyePoint Pharmaceuticals free cash flowTreace Medical Concepts free cash flow
EyePoint Pharmaceuticals & Treace Medical Concepts appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.